(WYNNEWOOD, PA; May 2007) --  If you smoke at least 10 cigarettes a day you may be eligible to enroll in a research study that compares the nicotine patch and the nicotine lozenge to help people quit smoking.

The Main Line Health Community Clinical Oncology Program at Lankenau, Bryn Mawr and Paoli Hospitals is partnering with Fox Chase Cancer Center to study the difference between the two nicotine replacement therapies.

The Nicotine Patch's popularity may be limited because it relies on a controlled flow of nicotine but lacks the oral gratification to simulate the smoking habit. In contrast, oral forms allow smokers to control the amount and timing of dosing and mimic the  smoking behavior.

Participants are randomly selected to receive either a 12-week supply of the nicotine patch or the nicotine lozenge. The study also involves five smoking cessation counseling sessions, one in person and four over the phone, and two clinical visits to complete their assessment. All nicotine replacements therapies and counseling sessions are provided at no cost to the participant.

To schedule an appointment or to learn more about the research program call 610-645-2395.

Published:5-3-2007